Actively Recruiting
To Compare the Efficacy and Safety of Using oXiris and M100 During CRRT
Led by Mohd Zulfakar Mazlan, MBBS · Updated on 2025-10-02
60
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study aimed to compare the efficacy of Oxiris (Baxter) and M100 filters on IL-6 as primary outcomes and other blood cell counts, blood biochemistry (serum urea, creatinine, potassium, sodium), inflammation indicators (CRP, PCT), as secondary outcomes and safety (28 days mortality as a primary outcome and coagulopathy, lifespan of filter, usage of vasopressor, clinical conditions (ventilator-free days, ICU and hospital- length of stay) as a secondary outcome), clinical conditions (ventilator-free days, ICU and hospital- length of stay), and mortality of patients with pneumonia-related AKI.
CONDITIONS
Official Title
To Compare the Efficacy and Safety of Using oXiris and M100 During CRRT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged over 18 years
- Diagnosis of septic shock
- Diagnosis of KDIGO stage 3 acute renal failure
You will not qualify if you...
- Moribund patients or those expected to die within 72 hours
- Pregnancy
- Patients with bleeding tendency or known allergy to heparin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Universiti Sains Malaysia (HUSM)
Kubang Kerian, Kelantan, Malaysia, 16150
Actively Recruiting
Research Team
M
Marina Azidah Mat Zaid, MBBS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here